Expression of lncRNA DLX6-AS1 in patients with hepatic carcinoma and its prognostic value-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Expression of lncRNA DLX6-AS1 in patients with hepatic carcinoma and its prognostic value

Published:2023-04-20 Issue: Volume: Page:1-12
ISSN:0264-8725
Container-title:Biotechnology and Genetic Engineering Reviews
language:en
Short-container-title:Biotechnology and Genetic Engineering Reviews

Author:

Lin Yonghua¹²,Zhang Baoyan³,Su Linfeng²,Wei Jianfeng¹²,Chen Zhichao¹²,Wu Min¹²

Affiliation:

1. Department of Hepatobiliary and Pancreatic Surgery, The Second Affiliated Hospital of Fujian Medical University, Quanzhou, Fujian, China

2. Surgery Teaching and Research Office of the Second Clinical Medical College of Fujian Medical University, Quanzhou, Fujian, China

3. Department of Clinical Pharmacy, The First Hospital of Quanzhou Affiliated to Fujian Medical University, Quanzhou, Fujian, China

Funder

his study was supported by the Startup Foundation project of Fujian Medical University

Publisher

Informa UK Limited

Subject

Molecular Biology,Bioengineering,Biotechnology

Link

https://www.tandfonline.com/doi/pdf/10.1080/02648725.2023.2204706

Reference24 articles.

1. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries

2. Increased expression of long non-coding RNA CCAT2 predicts poorer prognosis in patients with hepatocellular carcinoma

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP